FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913859518> ?p ?o ?g. }

• W2913859518 endingPage "100" @default.
• W2913859518 startingPage "87" @default.
• W2913859518 abstract "In this real-world, retrospective, comparative study we evaluated 6-month performance and safety in consecutive eyes following implantation of the iStent® or iStent inject® trabecular micro-bypass device with concomitant cataract surgery. Performance outcomes included intraocular pressure (IOP) reduction; glaucoma medication reduction; proportions of eyes achieving an IOP of < 18, < 16, < 14, or < 12 mmHg; and proportions of eyes on 0, 1, 2, or ≥ 3 medications. Safety outcomes included adverse events, secondary surgeries, and best-corrected visual acuity (BCVA). A total of 73 eyes with open-angle glaucoma and cataract were included in the study; of these, 38 eyes were implanted with the iStent device and 35 were implanted with the iStent inject device. The two groups of patients had similar baseline characteristics, with the exception of mean age and medication burden (both higher in patients receiving the iStent inject device); over 90% of eyes in both groups had early glaucoma. At 6 months after surgery, mean IOP had fallen from 16.5 ± 3.9 to 13.9 ± 2.3 mmHg in eyes with the iStent implant (p < 0.001), and from 17.3 ± 3.0 to 12.7 ± 1.8 mmHg in those with the iStent inject implant (p < 0.001). This reduction was significantly greater in the iStent inject eyes than in the iStent eyes (26.6 vs. 15.8%) (p = 0.005). Significantly more eyes receiving the iStent inject device compared to the iStent device achieved an IOP of < 18 mmHg at 6 months post surgery (100 vs. 86.8%) (p = 0.033). Average medication usage was reduced from 1.8 to 0.4 medications in iStent eyes (p < 0.001) and from 2.3 to 0.4 medications in iStent inject eyes (p < 0.001). Over 70% of eyes in both groups became medication-free by 6 months post implantation. Adverse events in iStent eyes were mild and resulted in no sequelae; two iStent eyes underwent non-penetrating deep sclerectomy during follow-up. No complications or secondary surgeries were noted in iStent inject eyes. All eyes in both groups maintained or showed improved BCVA versus baseline. Significant and safe IOP and medication reductions were observed after iStent or iStent inject implantation with concomitant cataract surgery. Trends toward greater effectiveness and fewer adverse events were observed with the iStent inject device compared with the iStent device. Article processing charges were provided by Glaukos Corporation." @default.
• W2913859518 created "2019-02-21" @default.
• W2913859518 creator A5008256207 @default.
• W2913859518 creator A5038914037 @default.
• W2913859518 creator A5043193727 @default.
• W2913859518 creator A5053543669 @default.
• W2913859518 creator A5074172751 @default.
• W2913859518 date "2019-02-05" @default.
• W2913859518 modified "2023-10-16" @default.
• W2913859518 title "Intermediate Results of iStent or iStent inject Implantation Combined with Cataract Surgery in a Real-World Setting: A Longitudinal Retrospective Study" @default.
• W2913859518 cites W1560493841 @default.
• W2913859518 cites W1690447342 @default.
• W2913859518 cites W1842399002 @default.
• W2913859518 cites W1904714596 @default.
• W2913859518 cites W1933043015 @default.
• W2913859518 cites W1966661538 @default.
• W2913859518 cites W1968070936 @default.
• W2913859518 cites W1974749862 @default.
• W2913859518 cites W1978548357 @default.
• W2913859518 cites W1984656953 @default.
• W2913859518 cites W1994586384 @default.
• W2913859518 cites W2006971510 @default.
• W2913859518 cites W2010842159 @default.
• W2913859518 cites W2027199310 @default.
• W2913859518 cites W2035998934 @default.
• W2913859518 cites W2037179295 @default.
• W2913859518 cites W2037276996 @default.
• W2913859518 cites W2062006189 @default.
• W2913859518 cites W2083909858 @default.
• W2913859518 cites W2091063199 @default.
• W2913859518 cites W2110897487 @default.
• W2913859518 cites W2129777105 @default.
• W2913859518 cites W2134263207 @default.
• W2913859518 cites W2137331306 @default.
• W2913859518 cites W2140594570 @default.
• W2913859518 cites W2148890166 @default.
• W2913859518 cites W2154392344 @default.
• W2913859518 cites W2158460199 @default.
• W2913859518 cites W2163393721 @default.
• W2913859518 cites W2166662563 @default.
• W2913859518 cites W2171709442 @default.
• W2913859518 cites W2236770805 @default.
• W2913859518 cites W2326530546 @default.
• W2913859518 cites W2473295892 @default.
• W2913859518 cites W2514189434 @default.
• W2913859518 cites W2518765452 @default.
• W2913859518 cites W2518988485 @default.
• W2913859518 cites W2525945327 @default.
• W2913859518 cites W2530686105 @default.
• W2913859518 cites W2531538920 @default.
• W2913859518 cites W2548353919 @default.
• W2913859518 cites W2598214833 @default.
• W2913859518 cites W2604874571 @default.
• W2913859518 cites W2611115414 @default.
• W2913859518 cites W2621585090 @default.
• W2913859518 cites W2772786820 @default.
• W2913859518 cites W2791269885 @default.
• W2913859518 cites W2792899705 @default.
• W2913859518 cites W2884103391 @default.
• W2913859518 cites W2888172313 @default.
• W2913859518 cites W2901160843 @default.
• W2913859518 cites W2901616068 @default.
• W2913859518 cites W4251596786 @default.
• W2913859518 doi "https://doi.org/10.1007/s40123-019-0166-x" @default.
• W2913859518 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6393257" @default.
• W2913859518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30721523" @default.
• W2913859518 hasPublicationYear "2019" @default.
• W2913859518 type Work @default.
• W2913859518 sameAs 2913859518 @default.
• W2913859518 citedByCount "43" @default.
• W2913859518 countsByYear W29138595182019 @default.
• W2913859518 countsByYear W29138595182020 @default.
• W2913859518 countsByYear W29138595182021 @default.
• W2913859518 countsByYear W29138595182022 @default.
• W2913859518 countsByYear W29138595182023 @default.
• W2913859518 crossrefType "journal-article" @default.
• W2913859518 hasAuthorship W2913859518A5008256207 @default.
• W2913859518 hasAuthorship W2913859518A5038914037 @default.
• W2913859518 hasAuthorship W2913859518A5043193727 @default.
• W2913859518 hasAuthorship W2913859518A5053543669 @default.
• W2913859518 hasAuthorship W2913859518A5074172751 @default.
• W2913859518 hasBestOaLocation W29138595181 @default.
• W2913859518 hasConcept C118487528 @default.
• W2913859518 hasConcept C126322002 @default.
• W2913859518 hasConcept C141071460 @default.
• W2913859518 hasConcept C167135981 @default.
• W2913859518 hasConcept C197934379 @default.
• W2913859518 hasConcept C2775888743 @default.
• W2913859518 hasConcept C2776508836 @default.
• W2913859518 hasConcept C2778257484 @default.
• W2913859518 hasConcept C2778527774 @default.
• W2913859518 hasConcept C2781092963 @default.
• W2913859518 hasConcept C71924100 @default.
• W2913859518 hasConceptScore W2913859518C118487528 @default.
• W2913859518 hasConceptScore W2913859518C126322002 @default.
• W2913859518 hasConceptScore W2913859518C141071460 @default.
• W2913859518 hasConceptScore W2913859518C167135981 @default.
• W2913859518 hasConceptScore W2913859518C197934379 @default.

• next